Skip to main content
. 2014 Dec 15;745:176–181. doi: 10.1016/j.ejphar.2014.10.041

Fig. 3.

Fig. 3

Agonist activity of peptides at human C5a1 and C3a receptors expressed in rat basophilic leukemia cells (RBL-2H3). Peptides were dissolved in DMSO and incubated at 50 μM with RBL-2H3 cells transfected with the appropriate receptor for 15 min. Degranulation was measured as the secretion of β-hexosaminidase. Results are expressed relative to maximal stimulation with 200 nM C5a (C5a1) or 100 nM hexapeptide agonist FLPLAR (C3a) after subtraction of background. Statistical significance of the difference from zero was assessed using a one-sample t test (P<0.05; ⁎⁎P<0.001). Bars are shaded according to peptide length (see Supplementary Table 2).